Clinical trials recruiting in Emmen, Netherlands

Phase breakdown

Conditions recruiting in Emmen, Netherlands

Recruiting trials in Emmen, Netherlands

• Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
  NCT07260435 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
  NCT06275958 · Phase: Phase 3 · Ages: 70 Years and older · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer
  NCT03941080 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
  NCT04833426 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer
  NCT07180381 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
  NCT06082492 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.
  NCT07234422 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
  NCT04436978 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Emmen, Netherlands?

11 recruiting trials have at least one study site in Emmen, Netherlands.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.